Alexandria Real Estate Equities, Inc. (ARE), with a market cap of $21.2 billion, is a leading urban office REIT specializing in life science, agtech, and technology campuses. Known for pioneering the life science real estate niche, the Pasadena, California-based company develops and operates high-quality, collaborative environments in key innovation clusters across North America.
Shares of this life science real estate company have underperformed the broader market over the past 52 weeks. ARE has risen 3.3% over this time frame, while the broader S&P 500 Index ($SPX) has gained 27%. In 2024, ARE stock declined 4.4%, compared to SPX's 18.1% YTD gain.
